Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HRH1 | P35367 | 19/20 | 0.59 |
| ▸ | CYP2D6 | P10635 | 15/20 | 0.59 |
| ▸ | KCNH2 | Q12809 | 9/20 | 0.59 |
| ▸ | CHRM1 | P11229 | 8/20 | 0.51 |
| ▸ | HTR2A | P28223 | 1/20 | 0.51 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6072807 | 0.87 | HRH1 (0.60) | HRH1CYP2D6KCNH2CHRM1HTR2A | |
| SCHEMBL6072764 | 0.81 | HRH1 (0.65) | HRH1CYP2D6KCNH2CHRM1HTR2A | |
| SCHEMBL6072870 | 0.81 | HRH1 (0.59) | HRH1CYP2D6KCNH2CHRM1HTR2A | |
| SCHEMBL6072929 | 0.80 | HRH1 (0.60) | HRH1CYP2D6KCNH2CHRM1HTR2A | |
| SCHEMBL6072714 | 0.80 | HRH1 (0.64) | HRH1CYP2D6KCNH2CHRM1HTR2A | |
| SCHEMBL6073411 | 0.79 | HRH1 (0.61) | HRH1CYP2D6KCNH2CHRM1HTR2A | |
| SCHEMBL4848913 | 0.78 | HRH1 (0.61) | HRH1CYP2D6KCNH2CHRM1HTR2A | |
| SCHEMBL6072831 | 0.78 | HRH1 (0.61) | HRH1CYP2D6KCNH2CHRM1HTR2A | |
| SCHEMBL6073263 | 0.78 | HRH1 (0.60) | HRH1CYP2D6KCNH2CHRM1HTR2A | |
| SCHEMBL6072749 | 0.77 | HRH1 (0.58) | HRH1CYP2D6KCNH2CHRM1HTR2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2006019497-A2 | SLEEP-INDUCING COMPOUNDS AND METHODS RELATED THERETO | NEUROCRINE BIOSCIENCES, INC. (US) | 2006-02-23 | — | — | WO | claimed |
| WO-2006019497-A2 | SLEEP-INDUCING COMPOUNDS AND METHODS RELATED THERETO | NEUROCRINE BIOSCIENCES, INC. (US) | 2006-02-23 | — | — | WO | disclosed |